series-a
Stage
1
Investors
About
Prologue Medicines develops programmable medicines by leveraging viral proteins to create novel therapeutics that modulate human physiology.
Explore Prologue Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.